Skip to main content
Premium Trial:

Request an Annual Quote

Herman Verrelst

Biocartis has appointed Herman Verrelst as its new CEO, effective as of August. Herman currently holds the position of VP and general manager of the genomics and clinical applications division of Agilent Technologies. He joined Agilent from Cartagenia, where he served as CEO and founder until it's acquisition by Agilent. He also served as CEO of Medicim, which was acquired by Swiss-based Nobel Biocare, in addition to serving as CEO and founder of DATA4s, which was acquired by Norkom Technologies.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.